Fine-Tuning Chronic Lymphocytic Leukemia Management: Optimising Bruton Tyrosine Kinase Inhibitor Use in Practice

Tailoring Bruton Tyrosine Kinase Inhibitor Strategies for CLL: Managing Today, Anticipating Tomorrow: Are you selecting the right Bruton tyrosine kinase (BTK) inhibitor for your patients with chronic lymphocytic leukemia (CLL)? Experts discuss the key differentiators and upcoming developments in the field. Credit available for this... by Keeping Current

38 min listen

Targeting BTK and Bcl-2 for B-Cell Malignancies: Where Are We Moving Toward?: Expert insights on the latest clinical findings on targeting Bruton tyrosine kinase (BTK) and B-cell lymphoma 2 (Bcl-2) to treat B-cell malignancies. Credit available for this activity expires: 1/12/25 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

21 min listen

Optimizing Treatment Pathways in CLL and MCL: Evaluating and Applying Recent Data on BTK Inhibitors: Do you struggle with how to optimally interpret chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL)? Hear from the experts. Credit available for this activity expires: 3/29/25 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

37 min listen

Bruton Tyrosine Kinase Inhibitors in B-Cell Malignancies: Multidisciplinary Perspectives on Managing and Maximizing Care: Do you know how adverse events (AEs) associated with Bruton tyrosine kinase (BTK) inhibitors affect patients’ lives and how best to manage these events? Credit available for this activity expires: 11/15/24 Earn Credit / Learning Objectives &... by Keeping Current

36 min listen

Primary Biliary Cholangitis: Targeting New Treatment Goals: How familiar are you with emerging therapies for primary biliary cholangitis (PBC)? Credit available for this activity expires: 3/28/25 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

15 min listen

Clinical Context of the Consensus: A Review of the Latest Recommendations for Waldenström Macroglobulinemia: Did you know that the latest guidelines for Waldenström macroglobulinemia now encompass second-generation Bruton tyrosine kinase inhibitors? Credit available for this activity expires: 10/16/24 Earn Credit / Learning Objectives & Disclosures: by Keeping Current

34 min listen

Relapsed/Refractory Chronic Lymphocytic Leukemia: The Evolving Role of BTK Inhibitors: Did you know that the National Comprehensive Cancer Network (NCCN) guidelines now include an investigational noncovalent BTK inhibitor for the treatment of relapsed/refractory CLL? Credit available for this activity expires: 12/05/24 Earn... by Keeping Current CME

29 min listen

$Relapsed/Refractory Chronic Lymphocytic Leukemia: The Evolving Role of BTK Inhibitors: Did you know that the National Comprehensive Cancer Network (NCCN) guidelines now include an investigational noncovalent BTK inhibitor for the treatment of relapsed/refractory CLL? Credit available for this activity expires: 12/05/24 Earn...$

Clinical Spotlight: Harnessing the Power of Antibody-Drug Conjugates in Non-Small Cell Lung Cancer: Antibody-drug conjugates are revolutionizing the therapeutic landscape for NSCLC. Are you up to date? Credit available for this activity expires: 1/24/2025 Earn Credit / Learning Objectives & Disclosures: by Keeping Current

38 min listen

BTK Inhibitors for Chronic Lymphocytic Leukemia: Rapid-Fire Highlights From the Past Year: Do you know what the latest chronic lymphocytic leukemia (CLL) clinical data are and what this could mean for your patients? Credit available for this activity expires: 8/10/2024 Earn Credit / Learning Objectives & Disclosures: by Keeping Current

19 min listen

Benjamin M. Greenberg, MD, MHS & Professor Anthony Traboulsee, MD - Bruton Tyrosine Kinase Inhibitors for MS: Progress in the Development of an Emerging Therapeutic Approach: Go online to PeerView.com/NXB860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. by PeerView Internal Medicine CME/CNE/CPE Audio Podcast

49 min listen

A Deep Dive Into Long-Term Efficacy and Safety of LDL-Cholesterol Lowering: Modern Strategies for ASCVD: Are you up to date on low-density lipoprotein cholesterol (LDL-C)–lowering therapy in high-risk patients? Credit available for this activity expires: 06/06/25 Earn Credit / Learning Objectives & Disclosures: by Keeping Current

32 min listen

Delivering Precision Oncology to Patients: From Principles to Practice: How can molecular profiling guide cancer therapy? Join our experts to learn how to best utilize molecular testing in clinical practice. Credit available for this activity expires: 5/30/25 Earn Credit / Learning Objectives & Disclosures: by Keeping Current

32 min listen

Optimizing Treatment Selection in Immune Thrombocytopenia: A Patient Case Discussion: Did you know that there is a tendency among clinicians to overuse corticosteroids in the management of immune thrombocytopenia (ITP)? Credit available for this activity expires: 6/26/24 Earn Credit / Learning Objectives & Disclosures: by Keeping Current

34 min listen